Role of Cardiac Magnetic Resonance Imaging in Heart Failure.

Cardiac magnetic resonance Etiology Heart failure Prognosis Treatment management

Journal

Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934

Informations de publication

Date de publication:
Apr 2021
Historique:
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 23 3 2021
Statut: ppublish

Résumé

This review describes the current role and potential future applications of cardiac magnetic resonance (CMR) for the management of heart failure (HF). CMR allows noninvasive morphologic and functional assessment, tissue characterization, blood flow, and perfusion evaluation. CMR overcomes echocardiography limitations (geometric assumptions, interobserver variability and poor acoustic window) and provides incremental information in relation to cause, prognosis, and treatment monitoring of patients with HF.

Identifiants

pubmed: 33673946
pii: S1551-7136(21)00001-5
doi: 10.1016/j.hfc.2021.01.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-221

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors declare no conflict of interests. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Carla Contaldi (C)

Department of Cardiology, University Hospital of Salerno, Via Enrico de Marinis, Cava de' Tirreni, Salerno 84013, Italy. Electronic address: contaldi.carla@gmail.com.

Santo Dellegrottaglie (S)

Division of Cardiology, Ospedale Accreditato Villa Dei Fiori, C.so Italia 157, Acerra, Naples I 80011, Italy; Zena and Michael A. Wiener Cardiovascular Institute/Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Ciro Mauro (C)

Cardiology Division, A Cardarelli Hospital, Via Cardarelli 9, Naples I 80131, Italy.

Francesco Ferrara (F)

Department of Cardiology, University Hospital of Salerno, Via Enrico de Marinis, Cava de' Tirreni, Salerno 84013, Italy.

Luigia Romano (L)

Department of General and Emergency Radiology, A Cardarelli Hospital, Via Cardarelli 9, Naples I 80131, Italy.

Alberto M Marra (AM)

Department of Translational Medical Sciences, Federico II University of Naples, Via Pansini 5, Naples I 80131, Italy.

Brigida Ranieri (B)

IRCCS SDN, Via Gianturco 113, Naples I 80143, Italy.

Andrea Salzano (A)

IRCCS SDN, Via Gianturco 113, Naples I 80143, Italy.

Salvatore Rega (S)

Department of Translational Medical Sciences, Federico II University of Naples, Via Pansini 5, Naples I 80131, Italy.

Alessandra Scatteia (A)

Division of Cardiology, Ospedale Accreditato Villa Dei Fiori, C.so Italia 157, Acerra, Naples I 80011, Italy.

Antonio Cittadini (A)

Department of Translational Medical Sciences, Federico II University of Naples, Via Pansini 5, Naples I 80131, Italy.

Filippo Cademartiri (F)

IRCCS SDN, Via Gianturco 113, Naples I 80143, Italy.

Eduardo Bossone (E)

Division of Cardiac Rehabilitation - Echo Lab, A Cardarelli Hospital, Via Cardarelli 9, Naples I 80131, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH